Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection.
Human T lymphotropic virus, type II (HTLV-II), infection has been shown to be endemic in a number of American Indian populations, and high rates of infection have also been documented in intravenous drug abusers in urban areas throughout the world. Although the role of HTLV-II in human disease has yet to be clearly defined, there is accumulating evidence that like HTLV-I, infection may also be associated with rare lymphoproliferative and neurological disorders. In this article we review and summarize the epidemiology, molecular properties and clinical features of HTLV-II infection.
Hall
W W
WW
Laboratory of Medical Virology, Rockefeller University, New York, New York, USA.
Ishak
R
R
Zhu
S W
SW
Novoa
P
P
Eiraku
N
N
Takahashi
H
H
Ferreira
M da C
Mda C
Azevedo
V
V
Ishak
M O
MO
Ferreira
O da C
Oda C
Monken
C
C
Kurata
T
T
D000595:Amino Acid Sequence; D001483:Base Sequence; D016356:Gene Products, tax / Q000737:chemistry; D015491:HTLV-II Infections / Q000175:diagnosis* / Q000453:epidemiology* / Q000635:transmission; D015367:Human T-lymphotropic virus 2 / Q000737:chemistry*; D006801:Humans; D007198:Indians, North American; D008969:Molecular Sequence Data; D010802:Phylogeny; D012091:Repetitive Sequences, Nucleic Acid / Q000235:genetics; D015819:Substance Abuse, Intravenous / Q000821:virology
D016356:Gene Products, tax